Autor: |
José M Ruiz-Moreno, María García‑Zamora, Jorge Ruiz‑Medrano |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
BMC Ophthalmology, Vol 23, Iss 1, Pp 1-7 (2023) |
Druh dokumentu: |
article |
ISSN: |
1471-2415 |
DOI: |
10.1186/s12886-023-03086-x |
Popis: |
Abstract Background The purpose is to report the second case, to our knowledge, of suspected paclitaxel-induced phototoxic maculopathy following pars plana vitrectomy surgery. Case presentation 63-year-old phakic female who underwent an uneventful phaco-vitrectomy to treat a complete macular hole, developing macular phototoxicity in the post-operatively period that could not be explained by the surgery itself and could only be attributed to a possible photosensitization induced by the previous use of paclitaxel. Conclusions The use of paclitaxel has been widely extended as a chemotherapy drug to treat breast cancer. It works by altering the intracellular microtubular reorganization and, based on this mechanism of action, photosensitivity has been previously described. We report a case of suspected paclitaxel-induced macular phototoxicity following ocular endoillumination during vitrectomy surgery. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|